MissionIR Articles

  • DARA BioSciences (DARA) Presents at Rodman & Renshaw Conference

    DARA BioSciences, Inc. (NASDAQ: DARA) is an oncology supportive care pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising…

  • CytRx (CYTR) Presents at Rodman & Renshaw Conference

    CytRx Corporation (NASDAQ: CYTR) is a biopharmaceutical research and development company specializing in oncology. CytRx is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic…

  • CytoSorbents (CTSO) Presents at Rodman & Renshaw Conference

    CytoSorbents Corp. (NASDAQ: CTSO) is a critical care immunotherapy company using blood purification to treat life-threatening illnesses. The company has developed a new hemoperfusion technology for removing toxins from the blood associated with sepsis, kidney…

  • CytoDyn (CYDY) Presents at Rodman & Renshaw Conference

    CytoDyn, Inc. (OTCQB: CYDY) is focused on developing new therapies that provide flexibility and freedom to people across the globe who are living with HIV. The company’s lead product, PRO 140, belongs to a new…

  • Cynapsus Therapeutics (CYNA) Presents at Rodman & Renshaw Conference

    Cynapsus Therapeutics, Inc. (NASDAQ: CYNA)  is a specialty central nervous system pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use, sublingual thin film for the on-demand turning ON of debilitating OFF episodes associated with…

  • Cymabay Therapeutics (CBAY) Presents at Rodman & Renshaw Conference

    Cymabay Therapeutics, Inc. (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on developing therapies to treat metabolic diseases with high unmet medical need or serious rare and orphan…

  • Cyclacel Pharmaceuticals (CYCC) Presents at Rodman & Renshaw Conference

    Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Professor Sir David Lane, a…

  • Critical Outcome Technologies (COTQF) Presents at Rodman & Renshaw Conference

    Critical Outcome Technologies, Inc. (OTC: COTQF) is engaged in disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small…

  • Cortex Pharmaceuticals (CORX) Presents at Rodman & Renshaw Conference

    Cortex Pharmaceuticals, Inc. (OTC: CORX) has multiple drug development programs targeted toward the treatment of brain-related breathing disorders, such as obstructive or central sleep apnea and drug-induced respiratory depression. One key program involves the development…

  • CorMedix (CRMD) Presents at Rodman & Renshaw Conference

    CorMedix, Inc. (NYSE: CRMD) is a commercial-stage biopharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. CorMedix’s first commercial product in Europe…

  • ContraVir Pharmaceuticals (CTRV) Presents at Rodman & Renshaw Conference

    ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) operates as a biopharmaceutical company focused on developing targeted antiviral therapies. The company has two drug candidates in clinical studies. The first, FV-100, is now in phase III trials and…

  • CombiMatrix (CBMX) Presents at Rodman & Renshaw Conference

    CombiMatrix Corp. (NASDAQ: CBMX) is a clinical diagnostic laboratory specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. As a full-scale cytogenetic and cytogenomic laboratory, CombiMatrix offers chromosomal microarray analysis, standard…

  • CoLucid Pharmaceuticals (CLCD) Presents at Rodman & Renshaw Conference

    Founded in 2005, biopharmaceutical company CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD) is focused on developing small molecules for the acute treatment of migraine headaches. The company’s lead product candidates are oral lasmiditan, an oral tablet for…

  • Codexis (CDXS) Presents at Rodman & Renshaw Conference

    Codexis, Inc. (NASDAQ: CDXS) provides unique, state-of-the-art enzyme optimization services and developing biocatalyst products. The company’s technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients (APIs), fine chemicals, agrochemicals, food ingredients, detergents and…

  • Clean Diesel Technologies (CDTI) Presents at Rodman & Renshaw Conference

    Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is a cleantech emissions control company that designs, develops and manufactures sustainable solutions to reduce emissions of on- and off-road engine applications. Within its sector, the company is a…

  • Cipher Pharmaceuticals (CPHR) Presents at Rodman & Renshaw Conference

    Cipher Pharmaceuticals, Inc. (NASDAQ: CPHR) is a dermatology company committed to offering healthcare professionals products that will better address their patients’ needs and enrich their practices. As such, the company’s innovative dermatology products provide efficacy,…

  • China XD Plastics Company (CXDC) Presents at Rodman & Renshaw Conference

    China XD Plastics Company Ltd. (NASDAQ: CXDC) engages in researching, developing, manufacturing and selling modified plastics primarily for automotive applications in China and Dubai, the United Arab Emirates. The company’s modified plastics are used to…

  • China Recycling Energy (CREG) Presents at Rodman & Renshaw Conference

    China Recycling Energy Corp. (NASDAQ: CREG) designs, finances, constructs, operates and transfers waste energy recycling projects to mid- to large-size enterprises involved in high energy-consuming businesses. The company offers waste pressure to energy systems, including…

  • China Jo-Jo Drugstores (CJJD) Presents at Rodman & Renshaw Conference

    China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), through its own retail drugstores, wholesale distributor and online pharmacy, is a retailer and wholesale distributor of pharmaceutical and healthcare products in China. As of March 31, 2015, the…

  • China Energy Technology (CETH) Presents at Rodman & Renshaw Conference

    China Energy Technology Corp., Ltd. (OTC: CETH) designs, manufactures, and sells solar water heaters and related solar products. The company offers vacuum tube solar energy collector, as well as the balcony flat panel solar energy…